(CRBN) Corbion - Ratings and Ratios

Corbion N.V. is a leading global provider of lactic acid and lactic acid derivatives, food preservation solutions, and algae ingredients, operating across multiple regions including Europe, North America, Asia, and Africa. The companys diverse product portfolio caters to various industries such as food, home and personal care, animal nutrition, pharmaceuticals, and bioplastics.

The companys operational structure is divided into two main segments: Functional Ingredients & Solutions and Health & Nutrition. Through these segments, Corbion N.V. offers a wide range of solutions, including acidification, food safety and preservation, health and nutrition, and taste and texture food solutions. Additionally, the company provides biochemical specialties, algae ingredients, and bioplastic products, showcasing its commitment to innovative and sustainable solutions.

Some of the key products offered by Corbion N.V. include Purasorb R&D, a custom synthesis solution; Puralact B3, a resin formulator for coatings and adhesives; Purasolv, a solvent for sustainable crop production; and AlgaVia, culinary algae oils. The companys products are marketed through a network of sales offices and distributors, ensuring a strong global presence.

From a technical analysis perspective, Corbion N.V.s stock (CRBN) is currently priced at 20.16 EUR, with a 20-day SMA of 19.41 EUR and a 50-day SMA of 18.56 EUR, indicating a positive trend. The 200-day SMA stands at 21.02 EUR, suggesting a potential resistance level. With an ATR of 0.38 EUR (1.89%), the stock has shown a relatively stable price movement. The 52-week high and low are 25.04 EUR and 16.76 EUR, respectively.

Fundamentally, Corbion N.V. has a market capitalization of 1121.30M EUR, with a P/E ratio of 25.06 and a forward P/E of 15.11, indicating a potentially undervalued stock. The companys RoE stands at 15.94%, demonstrating a decent return on equity. Considering the current technical and fundamental data, a forecast for Corbion N.V. could be as follows: given the positive trend indicated by the short-term SMAs and the relatively stable ATR, the stock is likely to continue its upward movement in the short term, potentially reaching the 21.02 EUR resistance level. However, if the companys fundamental strengths, such as its diverse product portfolio and global presence, continue to drive growth, the stock may eventually break through the resistance level and achieve a higher price. A potential target price could be around 23-24 EUR, representing a 10-15% increase from the current price.